Chronic thyroiditis in patients with advanced breast carcinoma: Metabolic and morphologic changes on PET-CT

European Journal of Nuclear Medicine and Molecular Imaging

Volumn 36, Issue 6, 2009, Pages 894-902

  Tateishi, Ukihide ^a,b   Gamez, Cristina ^a   Dawood, Shaheenah ^a   Yeung, Henry W D ^a   Cristofanilli, Massimo ^a   Inoue, Tomio ^b   MacApinlac, Homer A ^a  

^a UNIVERSITY OF TEXAS   (United States)

^b YOKOHAMA CITY UNIVERSITY   (Japan)

Author keywords

Clinical trials; FDG; PET; PET oncology; PET CT

Indexed keywords

FLUORODEOXYGLUCOSE F 18; TAMOXIFEN; THYROID HORMONE;

ADULT; ADVANCED CANCER; AGED; ARTICLE; BREAST CANCER; CHRONIC DISEASE; COMPUTER ASSISTED EMISSION TOMOGRAPHY; DRUG UPTAKE; FEMALE; GLYCOLYSIS; HORMONE SUBSTITUTION; HUMAN; HYPOTHYROIDISM; INCIDENTAL FINDING; MAJOR CLINICAL STUDY; MORPHOLOGY; THYROIDITIS; TOTAL LESION GLYCOLYSIS;

ADULT; AGED; AGED, 80 AND OVER; BREAST NEOPLASMS; CHRONIC DISEASE; FEMALE; FLUORODEOXYGLUCOSE F18; HUMANS; MIDDLE AGED; POSITRON-EMISSION TOMOGRAPHY; RETROSPECTIVE STUDIES; THYROID GLAND; THYROIDITIS; TOMOGRAPHY, X-RAY COMPUTED;

EID: 67349157003     PISSN: 16197070     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00259-008-1048-y     Document Type: Article

References (25)

1. QD Chu MS Connor DL Lillen LW Johnson RH Turnage BD Li 2006 Positron emission tomography (PET) positive thyroid incidentaloma: the risk of malignancy observed in a tertiary referral center Ann Surg 72 272 275
2. TY Kim WB Kim JS Ryu G Gog SJ Hong YK Shong 2005 18F-Fluorodeoxyglucose uptake in thyroid from positron emission tomogram (PET) for evaluation in cancer patients: high prevalence of malignancy in thyroid PET incidentaloma Laryngoscope 115 1074 1078
3. YK Chen YL Chen RH Cheng CL Yeh CC Lee CH Hsu 2007 The significance of FDG uptake in bilateral thyroid glands Nucl Med Commun 28 117 122
4. DT Schmid S Kneifel SJ Stoeckli BC Padberg G Merrill GW Goerres 2003 Increased 18F-FDG uptake mimicking thyroid cancer in a patient with Hashimoto's thyroiditis Eur Radiol 13 2119 2121
5. S Yasuda A Shohtsu M Ide S Takagi W Takanashi Y Suzuki 1998 Chronic thyroiditis: diffuse uptake of FDG at PET Radiology 207 775 778
6. AR Boerner E Voth P Theissen K Wienhard R Wagner H Schicha 1998 Glucose metabolism of the thyroid in Graves' disease measured by F-18-fluoro- deoxyglucose positron emission tomography Thyroid 8 765 772
7. G Wolf RM Aigner G Schaffler T Schwartz T Krippl 2003 Pathology results in [18F]fluorodeoxyglucose positron emission tomography of the thyroid gland Nucl Med Commun 24 1225 1230
8. MS Cohen N Arslan F Dehdashti GM Doherty TC Lairmore LM Brunt 2001 Risk of malignancy in thyroid incidentaloma identified by fluorodeoxyglucose-positron emission tomography Surgery 1309 41 46
9. M Salvatori L Melis P Castaldi ML Maussier V Rufini G Perotti 2007 Clinical significance of focal and diffuse thyroid diseases identified by 18F-fluorodeoxyglucose positron emission tomography Biomed Pharmacol 61 488 493
10. K Itoh N Maruchi 1975 Breast cancer in patients with Hashimoto's thyroiditis Lancet 2 1109 1112
11. LA Brinton DA Hoffman R Hoover JF Fraumeni Jr 1984 Relationship of thyroid disease and use of thyroid supplements to breast cancer risk J Chron Dis 37 877 893
12. S Franceschi C La Vecchia E Negri F Parazzini P Boyle 1990 Breast cancer risk and history of selected medical conditions linked with female hormones Eur J Cancer 26 781 785
13. M Cristofanilli Y Tamamura SW Kau T Bevers S Strom M Patangan 2005 Thyroid hormone and breast carcinoma. Primary hypothyroidism is associated with a reduced incidence of primary breast carcinoma Cancer 103 1122 1128
14. PP Smyth SG Shering MT Kilbane MJ Murray EW McDermott DF Smith 1998 Serum thyroid peroxidase autoantibodies, thyroid volume and outcome in breast carcinoma J Clin Endocrinol Metab 83 2711 2716
15. C Utech C Young P Winter 1996 Prospective evaluation of fluorine-18 fluorodeoxyglucose positron emission tomography in breast cancer for staging of axilla related to surgery and immunohistochemistry Eur J Nucl Med 23 1588 1593
16. F Crippa R Agresti E Seregni M Greco C Pascali A Bogni 1998 Prospective evaluation of fluorine-18 FDG PET in presurgical staging of axilla in breast cancer J Nucl Med 39 4 8
17. AY Rostom J Powe A Kandil A Ezzat S Bakheet F el-Khwsky 1999 Positron emission tomography in breast cancer: a clinicopathological correlation of results Br J Radiol 72 1064 1068
18. D Vranjesevic JE Filmont J Meta DH Silverman ME Phelps J Rao 2002 Whole-body (18)F-FDG PET and conventional imaging for predicting outcome in previously treated breast cancer patients J Nucl Med 43 325 329
19. SM Larson Y Erdi T Akhurst M Mazumdar HA Macapinlac RD Finn 1999 Tumor treatment response based on visual and quantitative changes in global tumor glycolysis using PET-FDG imaging: the visual response score and the change in total lesion glycolysis Clin Pos Imag 2 159 171
20. SG Jennings HT Winter-Muram RD Tarver MO Farber 2004 Lung tumor growth: assessment with CT - comparison of diameter and cross-sectional area with volume measurements Radiology 231 866 871
21. NF Col MI Surks GH Daniels 2004 Subclinical thyroid disease. Clinical applications JAMA 291 239 243
22. D Karantanis TV Bogsrud GA Wiseman BP Mullan RM Subramaniam MA Nathan 2007 Clinical significance of diffusely increased 18F-FDG uptake in the thyroid gland J Nucl Med 48 896 901
23. JG Guillem HG Moore T Akhurst DS Klimstra L Ruo M Mazumdar 2004 Sequential preoperative fluorodeoxyglucose-positron emission tomography assessment of response to preoperative chemoradiation: a means for determining longterm outcomes of rectal cancer J Am Coll Surg 199 1 7
24. L Wartofsky D Van Nostrand KD Burman 2006 Overt and 'subclinical' hypothyroidism in women Obstet Gynecol Surv 61 535 542
25. MI Surks E Ortiz GH Daniels CT Sawin NF Col RH Cobin 2004 Subclinical thyroid disease: scientific review and guidelines for diagnosis and management JAMA 291 228 238